Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Healthcare

    Tag: Healthcare

    You Searched For "Healthcare"
    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 9:18 AM GMT
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    MTaI to work closely with DoP, Invest India to promote investments in medical device sector

    MTaI to work closely with DoP, Invest India to promote investments in medical device sector

    Medical Dialogues Bureau30 Nov 2019 7:12 AM GMT
    "MTaI has been engaging with the Department of Pharmaceuticals and the Invest India team closely to work on several corrective measures which will...
    Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

    Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

    Medical Dialogues Bureau29 Nov 2019 3:45 AM GMT
    Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
    Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment

    Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment

    Medical Dialogues Bureau28 Nov 2019 3:40 AM GMT
    Sumit Sachdeva brings over 20 years of experience in the Healthcare Services industry having held global positions strategizing and driving growth...
    3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

    3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

    Farhat Nasim27 Nov 2019 6:29 AM GMT
    The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of...
    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Farhat Nasim25 Nov 2019 6:30 AM GMT
    The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the...
    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Medical Dialogues Bureau16 Nov 2019 3:50 AM GMT
    New Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Medical Dialogues Bureau15 Nov 2019 4:00 AM GMT
    The illegally imported drugs - made by Alpha Pharma in India - were shipped using Dhillon's contacts. Once in the UK they would be distributed by...
    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    Medical Dialogues Bureau13 Nov 2019 6:14 AM GMT
    Healthcare delivery sector is advancing at a lightening pace with doctors now capable to threatening many threatening diseases that earlier were...
    Fortis Healthcare reports net profit of Rs 124 crore for September quarter

    Fortis Healthcare reports net profit of Rs 124 crore for September quarter

    Medical Dialogues Bureau8 Nov 2019 3:50 AM GMT
    "The company continues to witness progressively improving quarters in both the hospitals and the diagnostics business," Fortis Healthcare Board...
    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    Medical Dialogues Bureau7 Nov 2019 10:50 AM GMT
    Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
    Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office

    Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office

    Medical Dialogues Bureau3 Nov 2019 4:25 AM GMT
    "The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok